Early Returns on Small Molecule Therapeutics for SARS-CoV-2-Reference-Cited by-同舟云学术

Early Returns on Small Molecule Therapeutics for SARS-CoV-2

Published:2021-01-08 Issue:6 Volume:7 Page:1298-1302
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Namchuk Mark N.¹^ORCID

Affiliation:

1. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts 02115, United States

Funder

Massachusetts Consortium for Pathogen Readiness

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.0c00874

Reference41 articles.

1. Why don’t some coronavirus patients sense their alarmingly low oxygen levels?

2. A review on drug repurposing applicable to COVID-19

3. Artificial intelligence, drug repurposing and peer review

4. Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges

5. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform;Journal of Biological Chemistry;2024-06

2. Natural and Synthetic Coumarins as Potential Drug Candidates Against SARS-CoV-2/CoViD-19;Current Medicinal Chemistry;2024-01-11

3. Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development;Frontiers in Molecular Biosciences;2023-03-09

4. Interactions of SARS-CoV-2 and MERS-CoV fusion peptides measured using single-molecule force methods;Biophysical Journal;2023-02

5. Identification and semisynthesis of (−)-anisomelic acid as oral agent against SARS-CoV-2 in mice;National Science Review;2022-08-26